MRVI

Maravai Lifesciences Holdings Stock Analysis

AI Rating

Neutral
  • Quality5/10
  • Growth↑ 5/10
  • Value↓ 0/10
Maravai Lifesciences Holdings sales and earnings growth
MRVI Growth
Neutral
  • Revenue Y/Y↓ -16.25%
  • EPS Y/Y↑ 37.72%
  • FCF Y/Y↓ -219.57%
Maravai Lifesciences Holdings gross and profit margin trends
MRVI Profitability
Low
  • Gross margin ↑ 29.30%
  • EPS margin↓ -51.10%
  • ROIC 5Y↓ 12.26%
Maravai Lifesciences Holdings net debt vs free cash flow
MRVI Risk
Great
  • Debt / Equity↓ 0.7
  • Debt / FCF↓ 2.0
  • Interest coverage↓ -3.2

Maravai Lifesciences Holdings stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks